AIMC Topic: Drug Discovery

Clear Filters Showing 21 to 30 of 1499 articles

Labels as a feature: Network homophily for systematically annotating human GPCR drug-target interactions.

Nature communications
Machine learning has revolutionized drug discovery by enabling the exploration of vast, uncharted chemical spaces essential for discovering novel patentable drugs. Despite the critical role of human G protein-coupled receptors in FDA-approved drugs, ...

M3S-GRPred: a novel ensemble learning approach for the interpretable prediction of glucocorticoid receptor antagonists using a multi-step stacking strategy.

BMC bioinformatics
Accelerating drug discovery for glucocorticoid receptor (GR)-related disorders, including innovative machine learning (ML)-based approaches, holds promise in advancing therapeutic development, optimizing treatment efficacy, and mitigating adverse eff...

OPTUNA optimization for predicting chemical respiratory toxicity using ML models.

Journal of computer-aided molecular design
Predicting molecular toxicity is an important stage in the process of drug discovery. It is directly related to medical destiny and human health. This paper presents an enhanced model for chemical respiratory toxicity prediction. It used a combinatio...

The QDπ dataset, training data for drug-like molecules and biopolymer fragments and their interactions.

Scientific data
The development of universal machine learning potentials (MLP) for small organic and drug-like molecules requires large, accurate datasets that span diverse chemical spaces. In this study, we introduce the QDπ dataset which incorporates data taken fr...

Artificial intelligence for RNA-ligand interaction prediction: advances and prospects.

Drug discovery today
Accurate prediction of RNA-ligand interactions is vital for understanding biological processes and advancing RNA-targeted drug discovery. Given their complexity, artificial intelligence (AI) is revolutionizing the study of RNA-ligand interactions, of...

DrugGen enhances drug discovery with large language models and reinforcement learning.

Scientific reports
Traditional drug design faces significant challenges due to inherent chemical and biological complexities, often resulting in high failure rates in clinical trials. Deep learning advancements, particularly generative models, offer potential solutions...

Advances in artificial intelligence-envisioned technologies for protein and nucleic acid research.

Drug discovery today
Artificial intelligence (AI) and machine learning (ML) have revolutionized pharmaceutical research, particularly in protein and nucleic acid studies. This review summarizes the current status of AI and ML applications in the pharmaceutical sector, fo...

Artificial intelligence in preclinical research: enhancing digital twins and organ-on-chip to reduce animal testing.

Drug discovery today
Artificial intelligence (AI) is reshaping preclinical drug research offering innovative alternatives to traditional animal testing. Advanced techniques, including machine learning (ML), deep learning (DL), AI-powered digital twins (DTs), and AI-enhan...

Ligand-Based Drug Discovery Leveraging State-of-the-Art Machine Learning Methodologies Exemplified by Cdr1 Inhibitor Prediction.

Journal of chemical information and modeling
Artificial intelligence (AI) is revolutionizing drug discovery with unprecedented speed and efficiency. In computer-aided drug design, structure-based and ligand-based methodologies are the main driving forces for innovation. In cases where no experi...

Addressing Imbalanced Classification Problems in Drug Discovery and Development Using Random Forest, Support Vector Machine, AutoGluon-Tabular, and H2O AutoML.

Journal of chemical information and modeling
The classification models built on class imbalanced data sets tend to prioritize the accuracy of the majority class, and thus, the minority class generally has a higher misclassification rate. Different techniques are available to address the class i...